DiaCarta Enters Contract with the VA Health Care System (San Francisco) for VEXAS Syndrome Testing
PLEASANTON, Calif., Oct. 3, 2024 /PRNewswire/ -- DiaCarta, a leading molecular diagnostic company specializing in oncology and infectious disease tests,...